[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-306932-105":3,"detail-sidebar-cat-1-en-105":81,"doc-detail-306932-en":127},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","healthcare-professional-agreement-to-supply-ulipristal-acetate-patient-group-direction-form","Healthcare Professional Agreement to Supply Ulipristal Acetate - Patient Group Direction Form","","This document serves as a formal agreement form for healthcare professionals authorized to supply Ulipristal Acetate (UPA-EC) under the Patient Group Direction (PGD) framework. It covers multiple NHS regions, including Grampian, Highland, Orkney, Shetland, Tayside, and Western Isles. By signing this agreement, the professional confirms they have completed the required specialized training and pledge to operate strictly within their professional competence and the specific guidelines provided by the PGD for emergency contraception services. This template ensures that medical staff are legally and professionally aligned with institutional standards before administering specified medications to patients. It requires detailed entry of the practitioner's name, area of practice, signature, date, professional designation, and registration PIN to ensure full accountability and compliance with health board regulations across the specified Scottish health service areas.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/template/","Template",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/template/forms/","Forms",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/template/healthcare-professional-agreement-to-supply-ulipristal-acetate-patient-group-direction-form/306932/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/healthcare-professional-agreement-to-supply-ulipristal-acetate-patient-group-direction-form/306932.png","ImageObject",442,249,{"name":42,"@type":43},"Hazel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-19",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of this form?","Question",{"text":63,"@type":64},"This form is a formal agreement for healthcare professionals to confirm their authorization and competence to supply Ulipristal Acetate for emergency contraception under a specific Patient Group Direction (PGD).","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which health regions does this agreement cover?",{"text":68,"@type":64},"The agreement applies to approved healthcare professionals working within the NHS regions of Grampian, Highland, Orkney, Shetland, Tayside, and the Western Isles.",{"name":70,"@type":61,"acceptedAnswer":71},"What are the responsibilities of the signatory?",{"text":72,"@type":64},"By signing, the professional confirms they have completed mandatory training, agree to remain within their professional competence, and adhere to all recommendations outlined in the Patient Group Direction.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},306932,1791357821,{"code":4,"msg":82,"data":83},"success",[84,89,94,99,104,109,113,118,123],{"id":85,"doc_module":22,"doc_module_name":25,"category_name":86,"show_sort_weight":87,"slug":88},11,"Presentations",90,"presentations",{"id":90,"doc_module":22,"doc_module_name":25,"category_name":91,"show_sort_weight":92,"slug":93},12,"Resumes",80,"resumes",{"id":95,"doc_module":22,"doc_module_name":25,"category_name":96,"show_sort_weight":97,"slug":98},14,"Invoices",70,"invoices",{"id":100,"doc_module":22,"doc_module_name":25,"category_name":101,"show_sort_weight":102,"slug":103},15,"Posters",60,"posters",{"id":105,"doc_module":22,"doc_module_name":25,"category_name":106,"show_sort_weight":107,"slug":108},16,"Social Media",50,"social-media",{"id":110,"doc_module":22,"doc_module_name":25,"category_name":29,"show_sort_weight":111,"slug":112},17,40,"forms",{"id":114,"doc_module":22,"doc_module_name":25,"category_name":115,"show_sort_weight":116,"slug":117},18,"Letters",30,"letters",{"id":119,"doc_module":22,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},21,"Paper Templates",5,"papers-templates",{"id":124,"doc_module":22,"doc_module_name":25,"category_name":125,"show_sort_weight":4,"slug":126},158,"General","general-158",{"code":4,"msg":82,"data":128},{"doc_id":79,"user_id":129,"nickname":42,"user_avatar":130,"doc_module":22,"category_id":110,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":131,"file_id":132,"file_url":133,"file_type":134,"file_size":135,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":22,"language":136,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":137,"faqs":138,"seo_title":139,"seo_description":12,"update_tm":140,"read_time":4},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Appendix 1  \n# Healthcare Professional Agreement to Supply Medicine(s)UnderPatient Group Direction\n\n                     (Insert name)  \nI:  \ne.g.Area,Practice  \nWorking within:                                            \nAgree to supply the medicine(s)contained within the following Patient Group Direction:  \nPatient Group Direction For The Supply Of Ulipristal AcetateEmergency Contraception (UPA-EC)By Approved HealthcareProfessionals Working Within NHS Grampian,Highland,Orkney,Shetland,Tayside And Western Isles  \nI have completed the appropriate training to my professional standards enabling me tosupply the medicine(s)under the above direction.I agree not to act beyond myprofessional competence,nor out with the recommendations of the direction.  \nSigned:  \nPrint Name:  \nDate:  \nProfession:  \nProfessional Registrationnumber/PIN:","cbCaiviu96jPXccI","https://ap.wps.com/l/cbCaiviu96jPXccI","pdf",135191,"English","# Healthcare Professional Agreement to Supply Medicine(s) Under Patient Group Direction\n## Professional Commitment and Authorization","[{\"question\":\"What is the purpose of this form?\",\"answer\":\"This form is a formal agreement for healthcare professionals to confirm their authorization and competence to supply Ulipristal Acetate for emergency contraception under a specific Patient Group Direction (PGD).\"},{\"question\":\"Which health regions does this agreement cover?\",\"answer\":\"The agreement applies to approved healthcare professionals working within the NHS regions of Grampian, Highland, Orkney, Shetland, Tayside, and the Western Isles.\"},{\"question\":\"What are the responsibilities of the signatory?\",\"answer\":\"By signing, the professional confirms they have completed mandatory training, agree to remain within their professional competence, and adhere to all recommendations outlined in the Patient Group Direction.\"}]","Healthcare Professional Agreement to Supply Ulipristal Acetate - Patient Group Direction Form | PDF",1789842579]